Loading clinical trials...
Loading clinical trials...
Cellular Senescence and Its Contribution to COVID-19 Long-Hauler Syndrome
Conditions
Locations
1
United States
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Start Date
March 1, 2021
Primary Completion Date
December 1, 2026
Completion Date
December 1, 2026
Last Updated
June 12, 2025
NCT05115617
NCT04470648
NCT06085547
NCT04896866
NCT05077969
NCT04957082
Lead Sponsor
Mayo Clinic
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions